BPG is committed to discovery and dissemination of knowledge
Case Control Study
©The Author(s) 2025.
World J Gastroenterol. Nov 28, 2025; 31(44): 112481
Published online Nov 28, 2025. doi: 10.3748/wjg.v31.i44.112481
Table 5 Diagnostic reliability analysis of serum biomarkers for hepatitis B virus-related hepatocellular carcinoma, (n/N, %)
Group
Sensitivity
Specificity
Accuracy
PPV
NPV
ORC165.56 (59/90, 0.551-0.750)54.84 (170/310, 0.493-0.603)57.25 (229/400, 0.523-0.621)29.65 (59/199, 0.235-0.365)84.58 (170/201, 0.792-0.889)
ESPL171.11 (64/90, 0.612-0.798)86.77 (269/310, 0.827-0.901)83.25 (333/400, 0.792-0.868)60.95 (64/105, 0.514-0.697)91.19 (269/295, 0.876-0.939)
AFP21.11 (19/90, 0.138-0.309)100.00 (310/310, 0.988-1.000)82.25 (329/400, 0.782-0.858)100.00 (19/19, 0.824-1.000)81.36 (310/381, 0.773-0.849)
ORC1 + ESPL1 + AFP84.44a,b (76/90, 0.756-0.909)84.19c (261/310, 0.798-0.879)84.25c (337/400, 0.803-0.876)60.80 (76/125, 0.521-0.690)94.91 (261/275, 0.917-0.971)


Write to the Help Desk